Massachusetts General Hospital is preparing to trial Tonix Pharmaceuticals’ nasally delivered potentiated oxytocin TNX-1900 in the treatment of binge eating disorder. Tonix is developing TNX-1900 as a treatment of chronic migraine, with a phase 2 clinical trial set to start in the indication in the second half of the year, but the delivery of the human […]

Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics. Oculis, a global ophthalmology company, announced on March 2, 2022 that it has formed a licensing agreement with Accure Therapeutics, a private translational neuroscience R&D company, granting Oculis exclusive global rights to develop and commercialize ACT-01, […]

Interleukin-2, a cytokine that helps the immune system fight disease, is an FDA-approved treatment, but it has been associated with selectivity, toxicity and dosing issues. Those shortcomings have inspired a wave of biotechs trying to create the next generation of IL-2 therapies. Now, Rice University researchers say they did so using beadlike implants. In a […]